Take a deep dive into decentralized clinical trials (DCTs). Here's what you'll learn from this insightful session: · How the COVID-19 pandemic catalyzed the evolution of today's DCTs · The subtle distinctions between traditional trials, DCTs, and hybrid models · Best practices for successful DCTs and a glimpse into what the future holds Get access to the webinar recording: https://ow.ly/50N650PPZt8. #DCTs #DecentralizedTrials #CitelineCCDW
Citeline Clinical’s Post
More Relevant Posts
-
We are proud to join forces with Greenphire, this partnership is a huge step in how we will create next generation products at Citeline. Read how our complementary datasets will support sponsors and CROs in clinical trial planning! https://ow.ly/2TwM50Tj6OZ.
-
Breaking News! Discover how Citeline Connect accelerated recruitment for the Monkeypox vaccine and delivered randomizations for 52% of the enrollment goal in just a few months. Read it now: https://ow.ly/5zGN50T4ZHG
-
Emerging clinical data shows CAR T-cell therapy has the potential to transform the treatment of autoimmune diseases, extending its impact beyond oncology. Learn the importance of making these innovative therapies accessible to more patients worldwide: https://ow.ly/PFuM50TiZms in partnership with ICON plc. Emily Merrell
-
-
In a recent Pharmacy Times article, Therapy Area Director Pam Spicer provides context for the current state of the Alzheimer’s drugs coming to market and their potential impact on physicians and patients: https://ow.ly/RKOF50Tjsbw. [Form completion may be required to access content.] #Lecanemab #Donanemab #Aducanumab
-
-
Our new collaboration with Greenphire presents a unique opportunity to solve the unmet needs of trial sponsors and CROs: https://ow.ly/E3H750TjpJq. Meet us next week at the DPHARM: Disruptive Innovations to Modernize Clinical Research Event in Philadelphia to discover how Citeline is your go-to clinical partner, supporting you from planning to patient recruitment.
-
HIV is a global health threat, with the at-risk population continuing to rise. Stephen Schrantz, MD at IQVIA shares his expert insight on overcoming these challenges in this Insight Brief: https://ow.ly/rn9H50TeEbv. Pre-exposure prophylaxis (PrEP) remains a highly effective drug, showing 99% effectiveness in preventing infections following exposure to HIV. However, with PrEP the standard of care for the virus, researchers face barriers in developing new prevention strategies.
-
Citeline's recruitment solutions and uniquely diversified, direct-to-data approach impact lives directly. VP Matt Holms gives an overview of our patient engagement and recruitment solutions: https://lnkd.in/gQy5wPEH. (15 minutes) #patientrecruitment #patientengagement #clinicaltrials #clinicaltrialenrollment
-
Citeline Connect seamlessly blends technology and services to expand recruitment channels and accelerate study enrollment: https://ow.ly/HGHL50SW9hM. This integrated, modular solution can be tailored to specific needs so you can effortlessly meet your enrollment targets.
